泛素
蛋白质水解
计算生物学
蛋白质降解
融合蛋白
化学
生物
纳米技术
细胞生物学
生物化学
材料科学
重组DNA
基因
酶
作者
Hanfeng Lin,Kristin M. Riching,May Poh Lai,Dong Lu,Ran Cheng,Xiaoli Qi,Jin Wang
标识
DOI:10.1101/2024.05.14.594249
摘要
Target protein degradation (TPD) has emerged as a revolutionary approach in drug discovery, leveraging the cell's intrinsic machinery to selectively degrade disease-associated proteins. Proteolysis-Targeting Chimeras (PROTACs) exemplify this strategy, exploiting heterobifunctional molecules to induce ubiquitination and subsequent degradation of target proteins. The clinical advancement of PROTACs underscores their potential in therapeutic intervention, with numerous projects progressing through clinical stages. However, monitoring subtle changes in protein abundance induced by TPD molecules demands highly sensitive assays. Nano-luciferase (nLuc) fusion proteins, or the NanoBiT technology derived from it, offer a robust screening platform due to their high sensitivity and stability. Despite these advantages, concerns have arisen regarding potential degradation artifacts introduced by tagging systems due to the presence of lysine residues on them, prompting the development of alternative tools. In this study, we introduce HiBiT-RR and nLuc
科研通智能强力驱动
Strongly Powered by AbleSci AI